Overview

• UnitedHealth reported second-quarter adjusted earnings of $4.08 per share on $111.6 billion in revenue, falling short of the $4.48 per share analysts expected.
• The company set its full-year 2025 adjusted earnings outlook at a minimum of $16 per share, well below the roughly $21 per share forecast by Wall Street.
• Shares of UnitedHealth have declined more than 40% year to date, marking their steepest slump in over a decade.
• CEO Stephen Hemsley, reinstated in May following Andrew Witty’s departure, is under pressure to outline plans to rein in soaring medical costs and shore up Optum Health margins.
• UnitedHealth confirmed it is cooperating with both criminal and civil U.S. Department of Justice investigations into its Medicare billing practices.